Stock Research for CGIX

CGIX

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

CGIX Stock Chart & Research Data

The CGIX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CGIX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


CGIX Due diligence Resources & Stock Charts

The CGIX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CGIX Detailed Price Forecast - CNN Money CNN View CGIX Detailed Summary - Google Finance
Yahoo View CGIX Detailed Summary - Yahoo! Finance Zacks View CGIX Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View CGIX Trends & Analysis - Trade-Ideas Barrons View CGIX Major Holders - Barrons
NASDAQ View CGIX Call Transcripts - NASDAQ Seeking View CGIX Breaking News & Analysis - Seeking Alpha
Spotlight View CGIX Annual Report - CompanySpotlight.com OTC Report View CGIX OTC Short Report - OTCShortReport.com
TradeKing View CGIX Fundamentals - TradeKing Charts View CGIX SEC Filings - Bar Chart
WSJ View Historical Prices for CGIX - The WSJ Morningstar View Performance/Total Return for CGIX - Morningstar
MarketWatch View the Analyst Estimates for CGIX - MarketWatch CNBC View the Earnings History for CGIX - CNBC
StockMarketWatch View the CGIX Earnings - StockMarketWatch MacroAxis View CGIX Buy or Sell Recommendations - MacroAxis
Bullish View the CGIX Bullish Patterns - American Bulls Short Pains View CGIX Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View CGIX Stock Mentions - StockTwits PennyStocks View CGIX Stock Mentions - PennyStockTweets
Twitter View CGIX Stock Mentions - Twitter Invest Hub View CGIX Investment Forum News - Investor Hub
Yahoo View CGIX Stock Mentions - Yahoo! Message Board Seeking Alpha View CGIX Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for CGIX - SECform4.com Insider Cow View Insider Transactions for CGIX - Insider Cow
CNBC View CGIX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CGIX - OTC Markets
Yahoo View Insider Transactions for CGIX - Yahoo! Finance NASDAQ View Institutional Holdings for CGIX - NASDAQ


Stock Charts

FinViz View CGIX Stock Insight & Charts - FinViz.com StockCharts View CGIX Investment Charts - StockCharts.com
BarChart View CGIX Stock Overview & Charts - BarChart Trading View View CGIX User Generated Charts - Trading View




Latest Financial News for CGIX


Cancer Genetics Offers Oncomine Comprehensive Assay to Drive Clinical Trials
Posted on Thursday September 20, 2018

RUTHERFORD, N.J., Sept. 20, 2018-- Cancer Genetics, Inc., a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and diagnostics, today announced the successful ...


Chardan Advises NovellusDX in Cross-Border Biotech Merger
Posted on Tuesday September 18, 2018

NEW YORK , Sept. 18, 2018 /PRNewswire/ -- Chardan, a global investment bank, announced today that the firm acted as exclusive financial advisor to NovellusDX, Ltd., a leader in functional genomics, for ...


Cancer Genetics and NovellusDx Sign Definitive Agreement to Merge
Posted on Tuesday September 18, 2018

Cancer Genetics, Inc. (CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, and NovellusDx, Ltd., a leader in functional genomics, today announced the signing of a definitive agreement under which NovellusDx will merge with a newly formed Israeli subsidiary of Cancer Genetics and shareholders of NovellusDx will receive stock equal to approximately 49% of the equity of Cancer Genetics on a fully diluted basis (with certain adjustments). Cancer Genetics will be the surviving entity and expects to remain listed on the Nasdaq Stock Market. This transaction will combine Cancer Genetics’ scale, expansive test portfolio and broad data set related to tumor biology, cultivated over more than a decade, with NovellusDx’s proprietary technology and machine learning capabilities to form a leading, oncology-focused precision medicine company.


Edited Transcript of CGIX earnings conference call or presentation 14-Aug-18 12:30pm GMT
Posted on Wednesday August 29, 2018

Q2 2018 Cancer Genetics Inc Earnings Call


Stock Market & Investing Books

Enter a stock symbol to view the stock details.